Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | YE232 | SYR / AR |
PATIENT DID NOT REPORT ANY ADVERSE EFFECTS; WE ARE REPORTING BECAUSE THE PATIENT HAD ALREADY RECIEVED THE RSV VACCINE AT A DIFFERENT PHARMACY ON 8/10/2023 AND THE RECOMMENDATION IS ONLY 1/LIFETIME
NONE REPORTED
CHLORTHALIDONE, ZOLPIDEM, ROSUVASTATIN, LOSARTAN
NO KNOWN ALLERGIES